Immunogenicity, Safety, Reactogenicity, Efficacy, Effectiveness and Lot Consistency of FluBlok

NCT00539981 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

4648

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza

Interventions

BIOLOGICAL: FluBlok®
BIOLOGICAL: Placebo

Sponsor

Sanofi

Collaborators

[object Object]